Select Agent (SA) Grams

2018 SA Grams

5/21/18 - Increase in Reports of Release Involving Integrity of Positive Pressure Encapsulating Suits

The Federal Select Agent Program (FSAP) has noticed an increase in reports of failures involving the integrity of the positive pressure encapsulating suits used in BSL-4 laboratories. A significant portion of these suit failures were identified during the exit chemical decontamination shower. As a result of these recent reports, we recommend entities maintaining BSL-4 laboratories consider the length of time a suit at the entity has been in service and conduct a more thorough examination of all suits, especially the seams and high wear areas, prior to entry into the BSL-4 laboratories.

If you have any questions regarding this email, please contact 301-851-3300 option 3 (voice only) or agsas@aphis.usda.gov for APHIS/AgSAS entities, and 404-718-2000 or LRSAT@CDC.gov for CDC/DSAT entities.




  • 5/10/18 - New FAQ to Assist with Completing FD-961 Form

    The Federal Select Agent Program (FSAP) has posted a new Frequently Asked Question (FAQ) on its website in order to assist individuals with completing the FBI/Criminal Justice Information Services (CJIS) Division’s FD-961 form (Application for Security Risk Assessment). The new FAQ is as follows:

    When completing question #6 (Position) in Section II (Individual Information) on the FD-961 form, what position should be listed?

    Please select the one of the following roles that best describes the individual’s primary responsibilities:

    • Administrative
    • Alternate Responsible Official
    • Animal Care Staff
    • IT
    • Laboratorian
    • Janitorial
    • Maintenance
    • Owner/Controller
    • Principal Investigator
    • Responsible Official
    • Safety
    • Security
    • Shipping/Receiving
    • Other for individuals who do not fall under one of the roles noted above

    The FAQ can be found at: https://www.selectagents.gov/faq-risk.html.

    If you have any questions regarding this email, please contact 301-851-3300 option 3 (voice only) or agsas@aphis.usda.gov for APHIS/AgSAS entities, and 404-718-2000 or LRSAT@CDC.gov for CDC/DSAT entities.

  • 5/08/18 - New eFSAP tools to assist users with APHIS/CDC Forms 2 & 4

    The Federal Select Agent Program (FSAP) has developed a series of reference guides to assist eFSAP users with the APHIS/CDC Form 2 and APHIS/CDC Form 4 eFSAP features. The reference guides are to provide a quick reference on how to input data by each section into eFSAP regarding APHIS/CDC Form 2 and APHIS/CDC Form 4.

    The quick reference guides are available online in the eFSAP Resource Center, and include the following materials:


    We hope that this information is helpful to you. If you have any questions related to the eFSAP system in general or with SAMS access to the system (e.g., log in problems, system outage) please contact the eFSAP customer support desk using the online help form, through email at eFSAPSupport@cdc.gov, or by phone at (877) 232-3322.

    If you have any questions regarding this email, please contact 301-851-3300 option 3 (voice only) or agsas@aphis.usda.gov for APHIS/AgSAS entities, and 404-718-2000 or LRSAT@CDC.gov for CDC/DSAT entities.

  • 5/08/18 - New FAQs Regarding Reporting Posted on FSAP Website

    The Federal Select Agent Program (FSAP) has posted new Frequently Asked Questions (FAQs) on its website in order to clarify requirements related to the reporting of the identification of a select agent or toxin in a clinical or diagnostic or proficiency testing specimen as outlined in sections 5, 6, and 9 of the select agent regulations. The new FAQs are as follows:

    As part of a proficiency test, I identified a select toxin but in an amount below the excluded threshold amount listed in 42 CFR § 73. 3. Must I still report the identification using an APHIS/CDC Form 4?

    Yes, regardless of the amount identified, a registered entity or a clinical or diagnostic laboratory is required to report the identification of a select toxin contained in a sample presented for proficiency testing using APHIS/CDC Form 4.

    As part of a proficiency test, I identified an excluded attenuated strain of a select agent. Must I still report the identification on APHIS/CDC Form 4?

    No. Any excluded attenuated strain of a select agent or toxin is excluded from the requirements of select agent regulations, including the reporting requirements set forth in sections 5 and 6 of the regulations. The list of excluded select agent strains can be found at https://www.selectagents.gov/SelectAgentsandToxinsExclusions.html.

    If a diagnostic test only identifies a biological agent at the genus level, am I required to report the result if I only suspect that it is select agent?

    No. but should further testing confirm that the specimen contains a select agent, the continued possession of that select agent is only exempt from the select agent regulations if the laboratory does the following:

    • Unless directed otherwise by AgSAS or DSAT, within seven (7) calendar days after identification of the select agent or toxin, either transfer the select agent or toxin in accordance with Section 16 of the select agent regulations (requires prior approval by AgSAS or DSAT) or destroy the specimen on-site by a recognized sterilization or inactivation process.
    • Before transfer or destruction, secure the select agent or toxin to prevent theft, loss, or release.
    • Immediately report the identification of specific select agents and toxins listed in the regulations (See immediate notification list).
    • Maintain copies of all APHIS/CDC Form 4A reports for a period of (3) three years.

    The FAQs can be found at: https://www.selectagents.gov/faq-reporting.html.

  • 5/07/18 - Additional user functionality for eFSAP: 1) data table redesigns, 2) file upload enhancements

    The Federal Select Agent Program (FSAP) is pleased to announce the deployment of additional functionality to the eFSAP system.

    Beginning May 7, 2018, authorized SAMS-account holders at all registered entities will be able to enjoy the following system-wide enhancements and additional functionality within eFSAP:

    System-wide data table redesign

    Data tables within eFSAP (e.g., amendment summary table, APHIS/CDC Form 2, 3, and 4 tables, document tables) have been completely redesigned to provide additional information and an enhanced user experience. Changes include:

    • Additional data columns have been added (e.g., APHIS/CDC Form 2 approval and expiration dates, APHIS/CDC Form 3 incident type).
    • Data table columns now have fixed column headers during scrolling.
    • Data tables support filtering and sorting of each data column independently for rapid retrieval of specific documents, amendments, and APHIS/CDC Forms 2, 3 and 4.

    File upload enhancements and additional functionality

    The file upload feature of eFSAP has been redesigned to aid in subsequent search and retrieval, organization and version control, and to provide transparency regarding the status of FSAP review.

    • eFSAP file upload now supports close to 700 different file types (e.g., .pdf, .doc, .rtf).
    • Entities are now able to add text descriptors and assign files to predefined categories during the upload process to aide in future file search and retrieval.
    • eFSAP now automatically generates unique versions of entity files with the same title to prevent overwrite and assist in keeping track of the most up-to-date copy of a file.
    • After file upload, entity users are able to see the status of FSAP review (e.g., not yet reviewed, under review by FSAP, review complete).

    Attached to this message is a tutorial with screenshots of the new features. In addition, you may reach out to your FSAP point of contact for assistance with these new features. If you experience errors or have questions related to the eFSAP system in general or with SAMS access to the system (e.g., log in problems, system outage) please continue to contact the eFSAP customer support desk using the online help form, through email at eFSAPSupport@cdc.gov, or by phone at (877) 232-3322.

  • 5/01/18 - Reminder regarding submission of Security Risk Assessment documentation

    The Federal Select Agent Program (FSAP) wishes to remind the regulated community that FSAP will not accept any information related to the FD-961 form (Application for Security Risk Assessment). The FD-961 form and photos required by the FBI must be sent as a pdf directly to the FBI’s Criminal Justice Information Services (CJIS) Division at FD961@leo.gov. An FD-961 form and/or photos submitted through eFSAP, to FSAP directly, or to any email except FD961@leo.gov will be deleted.

    Additional information regarding the security risk assessment is found at https://www.fbi.gov/services/cjis/bioterrorism-security-risk-assessment-form.

    FSAP appreciates your assistance in ensuring that any documentation related to the FD-961 form and appeals to restricted person notifications are sent appropriately.

    If you have any questions regarding this email, please contact the Federal Select Agent Program at 301-851-3300, option 3 (voice only) or agsas@aphis.usda.gov for APHIS/AgSAS entities, and 404-718-2000 or LRSAT@CDC.gov for CDC/DSAT entities.

  • 4/30/18 - OMB-approved FD-961 form now available from CJIS

    This email is being sent on behalf of the Federal Bureau of Investigation, Criminal Justice Information Services Division (CJIS) to notify you that the newly revised OMB-approved FD-961 form [OMB No. 1110-0039 (Exp. 4-30-2021)] has been posted online and is now available for use. The FD-961 form and the instructions can be found on the FBI's website at www.fbi.gov (search FD-961).

    If you have any questions regarding the FD-961 form, please contact CJIS at 304-625-4900.

  • 4/30/18 - Upcoming eFSAP Training: Register Now!

    In the coming days, the Federal Select Agent Program (FSAP) will be releasing extensive new functionality to the eFSAP system. This update brings users the ability to categorize files during the upload process and track the review status of documents that have been uploaded for FSAP review. Users will also be able to maintain, view, and retrieve multiple versions of their documents that have been uploaded over time. In addition, the pending update brings a redesign of data tables throughout the system, giving users the ability to filter and sort each table column independently for rapid retrieval of information.

    We have scheduled upcoming online training opportunities to assist you with using the new features. Online training sessions will be held between May 7-18, 2018. We encourage you to attend one of these training sessions.

    If you have any questions regarding this email, please contact the Federal Select Agent Program at 404-718-2000 or LRSAT@CDC.gov.

  • 4/23/18 - Save-the-Date: 2018 Responsible Official Workshop to be held August 15-17

    On August 15–17, 2018, the Federal Select Agent Program (FSAP) will hold a multi-day in-person workshop for Responsible Officials at the Centers for Disease Control and Prevention’s Roybal Campus in Atlanta, GA (1600 Clifton Road Atlanta, GA 30329). This year’s workshop will cover topics such as the use of eFSAP, inactivation, shipping, inspections, and APHIS/CDC Form 3 reporting, among other items. The format will include presentations and small group discussion sessions, as well as provide an opportunity to network with colleagues.

    The workshop is open only to Responsible Officials and Alternate Responsible Officials and limited to 200 participants. Information about registration and a detailed agenda will be provided in the coming weeks.

    If you have any questions regarding this email, please contact the Federal Select Agent Program at 301-851-3300 option 3 (voice only) or agsas@aphis.usda.gov for APHIS/AgSAS entities, and 404-718-2000 or LRSAT@CDC.gov for CDC/DSAT entities.

  • 3/13/18 - New eFSAP guidance to assist with user log on

    The Federal Select Agent Program (FSAP) is committed to providing the regulated community with an optimal eFSAP system user experience. In order to address and help troubleshoot log on issues that have been reported by some users, FSAP developed a reference guide containing reported issues and solutions. The guide is attached to this email and can be found online in the eFSAP Resource Center. We hope that this information is helpful to you in case you should experience one of the identified issues.

    If you have any questions related to the eFSAP system in general or with SAMS access to the system (e.g.,log in problems, system outage) please continue to contact the eFSAP customer support desk using the online help form, through email at eFSAPSupport@cdc.gov, or by phone at (877) 232-3322.

    If you have any questions regarding this email, please contact 301-851-3300 option 3 (voice only) or agsas@aphis.usda.gov for APHIS/AgSAS entities, and 404-718-2000 or LRSAT@CDC.gov for CDC/DSAT entities.

  • 3/06/18 - Reminder of Assistance Provided by Federal Bureau of Investigation Field Office Weapons of Mass Destruction Coordinator

    The below reminder is being sent on behalf of the Federal Bureau of Investigation, Weapons of Mass Destruction (WMD) Coordinator.

    The local Federal Bureau of Investigation Field Office WMD Coordinator provides assistance for registered entities regarding security. They should be contacted for support and assessments when suspicious behavior and activities are encountered, including cybersecurity-related issues. Biosecurity awareness training and exercises to prevent, detect, deter, and respond to threats to facilities, personnel, and research/inventory are also available.

    To engage this service, you can contact your Federal Bureau of Investigation WMD Coordinator (contact information found at http://www.fbi.gov/contact-us/field), provide identification, and request to be connected to the WMD Coordinator.


  • 3/05/18 - Updated Incident Response Plan Guidance and Template Now Available

    The Federal Select Agent Program (FSAP) has updated its Incident Response Plan Guidance and the associated template to help entities in developing a site-specific incident response plan to ensure the security and safeguarding of select agents and toxins from natural and man-made disasters. The documents are now available here.

    Draft versions of this guidance document and template were previously shared with the regulated community for review and input prior to being finalized.  The final documents do not reflect any major changes from the draft versions.

    If you have any questions regarding this email, please contact the Federal Select Agent Program at 301-851-3300 option 3 (voice only) or agsas@aphis.usda.gov for APHIS/AgSAS entities, and 404-718-2000 or LRSAT@CDC.gov for CDC/DSAT entities.


  • 3/02/18 - Additional user functionality for eFSAP (APHIS/CDC Form 1 Section 5 amendments, email notifications, and view-only users)

    The Federal Select Agent Program (FSAP) is pleased to announce the deployment of additional functionality to the eFSAP system.

    APHIS/CDC Form 1 Section 5 Amendments:
    Beginning immediately, Responsible Officials (ROs) and Alternate Responsible Officials (AROs) have the ability to perform the following activities directly in eFSAP:

    • Modify Section 5A: Entity-Wide Security Assessment and Incident Response
    • Modify Section 5B: Entity-Wide Biosafety/Biocontainment
    • Modify Section 5C: Entry Requirements for Federal Select Agent Program Inspectors

    Email Notifications:
    eFSAP also now supports email notifications.  Once daily, ROs and AROs will receive an email if FSAP staff have executed any action that generated a notification in an entity’s notification table.  The email will indicate that ROs and AROs should log into eFSAP at their earliest convenience to review the action.

    View-only Users:
    eFSAP has been configured to accept a new class of “view-only” users that have access to the system in the following manner:

    • Users of this class have view-only access to their entity’s registration information and APHIS/CDC Forms 2 – 4
    • Users of this class are able to upload documents to the document repository on behalf of the entity
    • Users of this class are able to download documents from their entity’s eFSAP document repository

    ROs are requested to provide FSAP with a list of individuals that they would like to have this level of access for their entity. For each individual, please provide the following information:

    • Entity name
    • First name, last name, email address (single line per person)

    You may send the list using the text box on the eFSAP customer support desk online help form or through email at eFSAPSupport@cdc.gov.

    Attached to this message is a short tutorial with screenshots of the new features. In addition, FSAP has posted a training video to walk users through the submission of Section 5 amendments.  For your awareness, FSAP also recently posted online a new video showing how to modify strains and serotypes in eFSAP (APHIS/CDC Form 1 Section 7).

    You may contact your FSAP point of contact for assistance with these new features.  If you experience errors or have questions related to the eFSAP system in general or with SAMS access to the system (e.g.,log in problems, system outage) please continue to contact the eFSAP customer support desk using the online help form or through email at eFSAPSupport@cdc.gov, or by phone at (877) 232-3322.

    If you have any questions regarding this email, please contact 301-851-3300 option 3 (voice only) or agsas@aphis.usda.gov for APHIS/AgSAS entities, and 404-718-2000 or LRSAT@CDC.gov for CDC/DSAT entities.


  • 2/28/18 - Updated Avian Influenza Virus Guidance Now Available

    The Agricultural Select Agent Services (AgSAS) has updated the document Avian Influenza Viruses, which provides guidance for the regulation of Avian Influenza, including categorization, biocontainment, and the transfer of Highly Pathogenic and Low Pathogenic Avian Influenza viruses. The updated document is now available here.

    This version of the document includes revisions to AgSAS contact information, updated figures from the more recent mid-west Avian Influenza outbreak, and language reflecting the Policy Statement (issued on February 2, 2018) regarding the live bird lethality testing requirements for pathogenicity testing of reverse genetically derived Avian Influenza Viruses.

    If you have any questions regarding this email, please contact AgSAS at 301-851-3300 option 3 (voice only) or agsas@aphis.usda.gov.

  • 2/14/18 - RO Workshop Presentations Now Available

    The Federal Select Agent Program (FSAP) recently posted presentations online from the November 28-30, 2017 in-person workshop for Responsible Officials held at the Animal and Plant Health Inspection Service headquarters in Riverdale, MD. The workshop provided participants with information about the new eFSAP information system portal, regulatory requirements for inactivation of select agents, and maintaining select agent regulatory compliance, as well as an opportunity to network with colleagues. The presentations are now available here.

    If you have any questions regarding this email, please contact 301-851-3300 option 3 (voice only) or agsas@aphis.usda.gov for APHIS/AgSAS entities, and 404-718-2000 or LRSAT@CDC.gov for CDC/DSAT entities.

  • 2/14/18 - New FAQs on FSAP Website

    The Federal Select Agent Program (FSAP) has posted new Frequently Asked Questions (FAQs) on its website in order to clarify regulatory requirements in two areas:


    Please see the corresponding web links for more information.

    If you have any questions regarding this email, please contact 301-851-3300 option 3 (voice only) or agsas@aphis.usda.gov for APHIS/AgSAS entities, and 404-718-2000 or LRSAT@CDC.gov for CDC/DSAT entities.


  • 2/13/18 - FSAP policy statement on chemical inactivation of whole tissue or homogenized tissue

    The Federal Select Agent Program (FSAP) has issued a new policy regarding the chemical inactivation of whole tissue or homogenized tissue.

    In meeting the in-house validation/verification of inactivation by chemical inactivation of whole tissue or homogenized tissue, it is FSAP policy to allow entities to select one tissue type (either (1) the tissue that is expected to have the highest concentration of the specific agent to be inactivated or (2) determine agent concentration for the agent to be inactivated in a tissue before performing inactivation to use as the maximum limit for that agent) to serve as a surrogate for other tissues, including those in other animal models, so long as all standardized conditions are held constant such as the agent used, tissue size, and ratio of tissue to volume of inactivating chemical. A safety margin must be incorporated into the final chemical inactivation procedure to ensure the effective inactivation of the agent.

    Please see the full policy for additional information. The policy is posted here.

    If you have any questions regarding this email, please contact 301-851-3300 option 3 (voice only) or agsas@aphis.usda.gov for APHIS/AgSAS entities, and 404-718-2000 or LRSAT@CDC.gov for CDC/DSAT entities.


  • 2/08/18 - AgSAS policy statement regarding biosafety level requirements for virulent Newcastle
    Disease virus

    The Agriculture Select Agent Services (AgSAS) has issued a policy statement regarding the biosafety level requirements for virulent Newcastle disease virus.

    It is the policy of the Agriculture Select Agent Services (AgSAS) that:

    • Any individual or entity conducting work with any non-exempted virulent Newcastle disease virus isolate must do so within an animal biosafety or biosafety level 3 (ABSL- or BSL-3) space, consistent with the Biosafety in Microbiological and Biomedical Laboratories recommendation for such agents.
    • An individual or entity may request a variance to this policy by submitting a request, accompanied by a risk assessment providing details of enhancements and preventative measures to mitigate work in a lower containment space, by email to AgSAS@aphis.usda.gov.

    The full policy is posted here.

    If you have any questions regarding this email, please contact AgSAS at 301-851-3300 option 3 (voice only) or agsas@aphis.usda.gov.


  • 2/02/18 - AgSAS policy statement regarding live bird lethality testing requirements for
    pathogenicity testing of reverse genetically derived viruses for avian influenza virus

    The Agriculture Select Agent Services (AgSAS) has issued a final policy statement regarding the removal of live bird lethality testing requirements for determining the pathogenicity characteristics of reverse genetically derived viruses, for avian influenza viruses.

    It is the policy of the Agriculture Select Agent Services (AgSAS) that:

    • We will accept reassortant virus exclusion requests, absent of live bird lethality testing data, for avian influenza constructs that meet specific criteria related to replication, cleavage site alteration, and gene insert characterization.
    • In lieu of the bird lethality testing, AgSAS will require all reverse genetically derived H5/H7 viruses with PR8 or similar human vaccine strain backbone to confirm genetic sequencing and demonstrate LPAI virus functionality through alternate requirements specified in the policy statement.

    The full policy is posted here.

    If you have any questions regarding this email, please contact AgSAS at 301-851-3300 option 3 (voice only) or agsas@aphis.usda.gov.


  • 2/05/18 - Update on Access Approval Expirations

    As the Federal Select Agent Program (FSAP) previously shared with the regulated community, the eFSAP system contains a feature to help Responsible Officials (ROs) monitor pending expiration of employee approval for access to select agents and toxins.  In the Section 4 screen of the APHIS/CDC Form 1 found in eFSAP, the system highlights when an individual’s access approval is about to expire.  To prevent an individual’s access to select agents and toxins from terminating unnecessarily, we recommend that any individual identified as needing a renewal (90 days from termination or “orange” designation) should immediately initiate the process for renewal by submitting a new form FD-961 to the Criminal Justice Information Services Division (CJIS).

    Should an individual’s access approval expiration date pass without having completed a renewal, FSAP will remove those individuals from the entity’s registration and their access to select agents and toxins will be revoked.  If this happens, the RO is responsible for requesting that the individual be added back to the registration.

    As previously shared, FSAP will no longer send out “expiring access approval” notification letters.  It is the responsibility of each RO to monitor the status of their entity’s individuals’ access approvals and ensure that the appropriate renewal paperwork is submitted in a timely manner.

    If you have any questions regarding this email, please contact 301-851-3300 option 3 (voice only) or agsas@aphis.usda.gov for APHIS/AgSAS entities, and 404-718-2000 or LRSAT@CDC.gov for CDC/DSAT entities.


  • 2/02/18 - Change in Leadership at the Agriculture Select Agent Services (AgSAS)

    The Federal Select Agent Program would like to announce a change in leadership at the Agriculture Select Agent Services (AgSAS). On Monday, February 5, 2018, Dr. Freeda Isaac will leave AgSAS to become the Executive Director of National Import Export Services, under Animal and Plant Health Inspection Service’s (APHIS) Veterinary Services.

    Also effective on February 5, Dr. Keith Wiggins will become AgSAS’ Acting National Director. Before this assignment, Dr. Wiggins served as the Associate National Director of AgSAS. Dr. Wiggins began his APHIS career in 2005. Throughout the last 13 years has served in leadership roles from enforcing regulations for the import of animal products and by-products to mitigate the introduction of foreign animal diseases, to ensuring that agricultural viruses, bacteria, and toxins are safeguarded to prevent agro-bioterrorism and public health threats. Prior to joining APHIS, Dr. Wiggins practiced veterinary medicine in North Carolina, was a Regional Veterinarian for Hill’s Pet Nutrition, and taught college courses at Livingstone College, the College of Southern Maryland, and Prince George’s Community College. Dr. Wiggins holds a Doctorate in Veterinary Medicine from Tuskegee University. He served as a Missile Launch Officer in the United States Air Force, and is currently serving as a Chief Public Health Officer in the New Jersey Air National Guard.

    If you have any questions regarding this email, please contact AgSAS at 301-851-3300 option 3 (voice only) or agsas@aphis.usda.gov.


  • 1/25/18 - Marijuana Use by Individuals Approved for Access to Select Agents and Toxins

    It is has come to the attention of the Federal Select Agent Program (FSAP) that there may be some confusion within the regulated community concerning the use of marijuana by individuals approved for access to select agents and toxins in states where some use of marijuana is now legal as a matter of state law.    

    Responsible Officials need to clearly understand and communicate to persons within their entity, that any person who uses marijuana or holds a medical marijuana card, regardless of state law, is considered by the Federal Government to be an unlawful user of a controlled substance and is therefore a “restricted person” and prohibited by federal law from having access to select agents and toxins.

    If you have any questions regarding this email, please contact 301-851-3300 option 3 (voice only) or AgSAS@aphis.usda.gov for APHIS/AgSAS entities, and 404-718-2000 or lrsat@cdc.gov for CDC/DSAT entities.

  • 1/17/18 - Exclusion of Burkholderia pseudomallei and Burkholderia malleistrains

    Based upon consultations with subject matter experts and a review of relevant published studies and information provided by the entities requesting the exclusions, the Federal Select Agent Program has determined that several attenuated strains of Burkholderia pseudomallei and Burkholderia mallei are not subject to the requirements of the select agent regulations.  These exclusions include:

    • Nine Burkholderia pseudomallei Δasd strains
    • Four Burkholderia mallei Δasd strains

    Additional information regarding the specific excluded strains can be found here.

    If you have any questions regarding this email, please contact 301-851-3300 option 3 (voice only) or AgSAS@aphis.usda.gov for APHIS/AgSAS entities, and 404-718-2000 or lrsat@cdc.gov for CDC/DSAT entities.


  • 1/12/18 - Use of eFSAP for Immediate Notification Submissions (APHIS/CDC Forms 3 and 4A)

    The Federal Select Agent Program (FSAP) would like to ensure eFSAP users are aware that they can now submit immediate notifications for APHIS/CDC Form 3 and APHIS/CDC Form 4A directly to FSAP via the system.

    Attached to this message are tutorials with screenshots detailing these features.  (Available here).  

    eFSAP users may access the system at https://fsap.cdc.gov.  If you experience errors or have questions related to the eFSAP system in general or with SAMS access to the system (e.g.,log in problems, system outage) please continue to contact the eFSAP customer support desk using the online help form, through email at eFSAPSupport@cdc.gov, or by phone at (877) 232-3322.   You may also wish to visit our online eFSAP Resource Center

    If you have any questions regarding this email, please contact 301-851-3300 option 3 (voice only) or agsas@aphis.usda.gov for APHIS/AgSAS entities, and 404-718-2000 or LRSAT@CDC.gov for CDC/DSAT entities.


  • 1/09/18 - Additional eFSAP Training Videos Now Available

    The Federal Select Agent Program (FSAP) has recently posted several additional online videos to assist users with completing tasks in the electronic Federal Select Agent Program portal, eFSAP.

    The new videos, available here, will help users complete functions associated with APHIS/CDC Forms 1 – 4 and include the following:

    • How to change an entity’s name, abstract, or type (Form 1 Section 1 amendments)
    • How to change an entity’s physical or additional address (Form 1 Section 1 amendments)
    • How to add personnel to an entity’s registration (Form 1 Section 4 amendments)
    • How to submit an APHIS/CDC Form 2 Section 1
    • How to submit an APHIS/CDC Form 2 Section 2
    • How to submit an APHIS/CDC Form 2 Section 3
    • How to submit an APHIS/CDC Form 3
    • How to submit an APHIS/CDC Form 4a Sections a and b
    • How to submit an APHIS/CDC Form 4a Sections c and d
    • How to submit an APHIS/CDC Form 4b

    Additional resources will continue to be posted to this page as they become available.

    If you have any questions regarding this email, please contact the Federal Select Agent Program at 301-851-3300 option 3 (voice only) or agsas@aphis.usda.gov for APHIS/AgSAS entities, and 404-718-2000 or LRSAT@CDC.gov for CDC/DSAT entities.